Editorial Expression of Concern: Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia.

Saved in:
Bibliographic Details
Title: Editorial Expression of Concern: Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia.
Authors: Wu H; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China.; University of Science and Technology of China, Anhui, Hefei, P. R. China., Hu C; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Wang A; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China.; University of Science and Technology of China, Anhui, Hefei, P. R. China., Weisberg EL; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Chen Y; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Yun CH; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Wang W; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Liu Y; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Liu X; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China.; University of Science and Technology of China, Anhui, Hefei, P. R. China., Tian B; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Science Key Laboratory, Beijing, China., Wang J; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Zhao Z; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Liang Y; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Li B; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Wang L; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Wang B; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Chen C; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Buhrlage SJ; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Qi Z; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Zou F; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Nonami A; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Li Y; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Fernandes SM; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Adamia S; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Stone RM; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Galinsky IA; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Wang X; Department of Lymphoma, Sino-US Center for Lymphoma and Leukemia, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China., Yang G; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Griffin JD; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Brown JR; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Eck MJ; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Liu J; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China. jingliu@hmfl.ac.cn., Gray NS; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. Nathanael_Gray@dfci.harvard.edu., Liu Q; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China. qsliu97@hmfl.ac.cn.; University of Science and Technology of China, Anhui, Hefei, P. R. China. qsliu97@hmfl.ac.cn.; Hefei Science Center, Chinese Academy of Sciences, Hefei, Anhui, China. qsliu97@hmfl.ac.cn.
Source: Leukemia [Leukemia] 2026 Jun; Vol. 40 (6), pp. 1342.
Publication Type: Expression of Concern
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1476-5551
DOI:10.1038/s41375-026-02980-9